EURICAN DAP LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION
EURICAN DAP LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION
Not authorised
- Water for injection
- Canine distemper virus, strain BA5, Live
- Canine parvovirus, strain CAG2, Live
- Canine adenovirus 2, strain DK13, Live
Product identification
Medicine name:
EURICAN DAP LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION
Eurican DAP liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai
Active substance:
- Water for injection
- Canine distemper virus, strain BA5, Live
- Canine parvovirus, strain CAG2, Live
- Canine adenovirus 2, strain DK13, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Water for injection1.00/millilitre(s)1.00Dose
-
Canine distemper virus, strain BA5, Live10000.00/50% cell culture infectious dose1.00Dose
-
Canine parvovirus, strain CAG2, Live79432.00/50% cell culture infectious dose1.00Dose
-
Canine adenovirus 2, strain DK13, Live316.00/50% cell culture infectious dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Not applicableno withdrawal periodWithdrawal period is 0 days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Latvia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/MRP/16/0007
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0305/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 16/10/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 16/10/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 16/10/2024